Filing Flows › Bruker (BRKR) › Guidance & outlook
Bruker (BRKR) guidance and outlook
Bruker (BRKR) lowered its guidance on Nov 4, 2026: Revenue $3.5B–$3.6B for FY2026; Revenue +2.5% to +3.5% for FY2026; EPS $2.10–$2.15 for FY2026. Bruker's 10-Q filed Nov 5, 2026 makes 16 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $3.5B–$3.6B | lowered |
| Revenue | FY2026 | +2.5% to +3.5% | lowered |
| EPS | FY2026 | $2.10–$2.15 | reaffirmed |
From the earnings release filed Nov 4, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 5, 2026
- any other statements that address events or developments that we intend or believe will or may occur in the future.
- our ability to identify suitable acquisition targets and successfully integrate and manage acquired businesses; and
- During the third quarter of 2026, changes in the competitive landscape and operating results below expectations led us to lower our expectations for the BSB&CA reporting unit, including our long-term forecasted revenue and cash flows.
- Significant assumptions in the discounted cash flow model included, but were not limited to, discount rates ranging from 11.0% to 14.0%, revenue growth rate assumptions at the higher end of the projected ranges for our other significant businesses, and, for the impairment test performed in the third quarter of 2026, operating margin rate assumptions that were lower than those of the Company’s other significant…
- During the second quarter of 2026, we reduced our forecasted revenue and cash flows for the CST (formerly Automation) reporting unit.
- Significant assumptions in the discounted cash flow model included, but were not limited to, a discount rate of 13.5% and revenue growth and operating margin rate assumptions at the lower end of the projected ranges for our other significant businesses.
- We will continue to monitor circumstances and uncertainties that may impact the carrying value of our reporting units, including current macroeconomic conditions and the timing and quantity of future cash flows.
- These tariff measures and the related uncertainty in global trade markets have contributed to lower‑than‑anticipated bookings, revenues, and profitability, and may continue to adversely affect our business for the foreseeable future.
- Our income tax provision for the three and nine months ended September 30, 2026, reflected currently enacted legislation and guidance related to Pillar Two.
- This enacted legislation and guidance did not have a material impact on our income tax provision for the three and nine months ended September 30, 2026.
- We continue to evaluate the Side-by-Side guidance and monitor the countries in which we operate as they enact legislation implementing Pillar Two.
- We anticipate that our existing cash and cash equivalents and credit facilities will be sufficient to support our operating and investing needs, and other liquidity needs, for at least the next twelve months and the foreseeable future under the currently anticipated business conditions and macroeconomic environment.
Bruker's latest quarter
Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%, net loss $110M, operating cash flow $118M. The chart follows the revenue to costs, profit and cash.
Questions
Did Bruker raise or lower its guidance?
Bruker (BRKR) lowered its guidance on Nov 4, 2026: Revenue $3.5B–$3.6B for FY2026; Revenue +2.5% to +3.5% for FY2026; EPS $2.10–$2.15 for FY2026.
What does Bruker expect?
any other statements that address events or developments that we intend or believe will or may occur in the future. our ability to identify suitable acquisition targets and successfully integrate and manage acquired businesses; and During the third quarter of 2026, changes in the competitive landscape and operating results below expectations led us to lower our expectations for the BSB&CA reporting unit, including our long-term forecasted revenue and cash flows.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.